Reports of society meetings and concensus conferences: International concensus on oesophageal reflux disease;Aus fachgremien and konsensuskonferenzen: Internationaler konsens zur refluxkrankheit der speiserohre

Deutsche Medizinische Wochenschrift

Volumn 125, Issue 43, 2000, Pages 1308-1312

  Hotz, J ^a   Madisch, A ^a   Classen, M ^a   Malfertheiner, P ^a   Rosch, W ^a  

^a ALLGEMEINES KRANKENHAUS CELLE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; CONFERENCE PAPER; ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; PATHOPHYSIOLOGY; REFLUX ESOPHAGITIS; STOMACH RADIOGRAPHY; CLASSIFICATION; CONSENSUS DEVELOPMENT; EUROPE; GASTROESOPHAGEAL REFLUX; HUMAN;

ESOPHAGITIS, PEPTIC; EUROPE; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 0034721641     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7994     Document Type: Conference Paper

References (20)

1. Relationship between symptoms, endocopic findings and treatment outcome in reflux esophagitis
2. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: A meta-analysis of long-term omeprazole trials
3. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
4. An evidence-based appraisal of reflux disease management - The genval workshop report
5. Management of symptoms of gastroesophageal reflux disease: Does endoscopy influence medical management?
6. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis
7. Timing of reflux symptoms and esophageal acid exposure
8. Gastroesophageal reflux in obese patients is not reduced by wewight reduction
9. Helicobacter pylori in gastro-oesophageal reflux disease: Causal agent, independent or protective factor?
10. Contra Chirurgie bei gastroosophagelaer Refluxkrankheit
11. Endoscopic assessment of oesophagitis: Clinical and functional correlats and further validation of the Los Angeles classification
12. Optimierte Osophagoskopie
13. Short segment Barrett's oesophagus: Prevalence, diagnosis and associations
14. Failure of initial 24-hour esophageal pH monitoring to predict refractoriness and intractability in reflux esophagitis
15. The effect of posture on gastroesophageal reflux event frequency and composition during fasting
16. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett
17. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in gerneral practice
18. A comparison of five maintenance therapies for reflux esophagitis
19. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitsi
20. Endoscopy has a positive impact on quality of life in dyspepsia